Health Law & Business News

Antitrust Officers Eye Cross-Sector Health Deals, Pharma (1)

May 14, 2019, 6:40 PMUpdated: May 14, 2019, 8:07 PM

Antitrust enforcers are raising red flags about competition in health care as lawmakers ramp up their focus on the same issues.

Two Democratic Federal Trade Commission commissioners spoke about a need for more information about changes in the health-care market at different events May 14.

Commissioner Rebecca Kelly Slaughter said the FTC should systematically review past mergers with a focus on how deals across healthy industry sectors may have changed the competitive landscape. Meanwhile, Commissioner Rohit Chopra said he wants to spend more time examining the shadowy system of pharmaceutical rebates.

Their remarks come as the Senate Judiciary Committee plans...

To read the full article log in. To learn more about a subscription click here.